Rozemeijer, Rik <br/><br/>
Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry.  [electronic resource] 

 -  Cardiovascular revascularization medicine : including molecular interventions  07 2018 
 - 521-525 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1878-0938 
<br/><br/><label>Standard No.: </label>10.1016/j.carrev.2017.10.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Cardiovascular Agents--administration & dosage<br/>Coronary Artery Disease--diagnostic imaging<br/>Coronary Restenosis--etiology<br/>Coronary Thrombosis--etiology<br/>Diabetes Mellitus--diagnosis<br/>Drug-Eluting Stents<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Percutaneous Coronary Intervention--adverse effects<br/>Progression-Free Survival<br/>Prosthesis Design<br/>Registries<br/>Retrospective Studies<br/>Risk Factors<br/>Sirolimus--administration & dosage<br/>Time Factors